Results 11 to 20 of about 251 (129)

Chronic Obstructive Pulmonary Disease Combined with Interstitial Lung Disease [PDF]

open access: yesTuberculosis and Respiratory Diseases, 2022
Although chronic obstructive pulmonary disease (COPD) and interstitial lung disease (ILD) have distinct clinical features, both diseases may coexist in a patient because they share similar risk factors such as smoking, male sex, and old age.
Joon Young Choi   +2 more
doaj   +1 more source

An increased risk of lung cancer in combined pulmonary fibrosis and emphysema patients with usual interstitial pneumonia compared with patients with idiopathic pulmonary fibrosis alone: a systematic review and meta-analysis

open access: yesTherapeutic Advances in Respiratory Disease, 2021
Background: Lung cancer is an important complication of combined pulmonary fibrosis and emphysema (CPFE). Whether the risk of lung cancer is higher in CPFE patients with usual interstitial pneumonia (UIP) than those with idiopathic pulmonary fibrosis ...
Qianqian Chen   +4 more
doaj   +1 more source

CPFE Supplement

open access: yes, 2023
Supplemental Figures and ...
openaire   +2 more sources

Combined Pulmonary Fibrosis and Emphysema Syndrome Complicated by Lung Cancer

open access: yesSouthern Clinics of Istanbul Eurasia, 2018
Combined pulmonary fibrosis and emphysema syndrome (CPFE) is a rare disease characterized by emphysema in the upper lobes of the lung and fibrosis in the lower lobes. CPFE is an important risk factor for lung cancer (LC). Although CPFE might increase the
Nesrin Kıral Gürbüz   +5 more
doaj   +1 more source

An increased risk of pulmonary hypertension in patients with combined pulmonary fibrosis and emphysema: a meta-analysis

open access: yesBMC Pulmonary Medicine, 2023
Background and aim Pulmonary hypertension (PH) is a common complication of combined pulmonary fibrosis and emphysema (CPFE). Whether the incidence of PH is increased in CPFE compared with pure pulmonary fibrosis or emphysema remains unclear.
Hangqi Ni   +3 more
doaj   +1 more source

Alveolar and interstitial disease in chronic smoker presenting as combined pulmonary fibrosis with emphysema: Double trouble!

open access: yesAnnals of Medical Science and Research, 2023
Tobacco smoke exposure causes diverse pulmonary manifestations with involvement of alveolar, interstitial, and vascular diseases due to inflammatory pathology apart from more lethal lung cancer. Combined pulmonary fibrosis and emphysema is a heterogenous
Shital Patil, Gajanan Gondhali
doaj   +1 more source

Adenosine and hyaluronan promote lung fibrosis and pulmonary hypertension in combined pulmonary fibrosis and emphysema

open access: yesDisease Models & Mechanisms, 2019
Combined pulmonary fibrosis and emphysema (CPFE) is a syndrome that predominantly affects male smokers or ex-smokers and it has a mortality rate of 55% and a median survival of 5 years.
Scott D. Collum   +18 more
doaj   +1 more source

Combined pulmonary fibrosis and emphysema and idiopathic pulmonary fibrosis in non-small cell lung cancer: impact on survival and acute exacerbation

open access: yesBMC Pulmonary Medicine, 2019
Background In non-small cell lung cancer (NSCLC) patients, concomitant idiopathic pulmonary fibrosis (IPF) and emphysema (CPFE) are independently related to poor survival. CPFE is a condition with features of both pulmonary fibrosis and emphysema.
Sung Woo Moon   +11 more
doaj   +1 more source

Prognosis of patients with acute exacerbation of combined pulmonary fibrosis and emphysema: a retrospective single-centre study

open access: yesBMC Pulmonary Medicine, 2020
Background Previous analyses of combined pulmonary fibrosis and emphysema (CPFE) cohorts have provided conflicting data on the survival of patients with CPFE.
Yuichi Ikuyama   +11 more
doaj   +1 more source

CPFE Syndrome: A Case Report

open access: yesInternational Journal of Medical Science and Clinical invention, 2019
Combined pulmonary fibrosis and emphysema syndrome (CPFE syndrome) is the co-existence of emphysema and pulmonary fibrosis in individuals. The syndrome was first described by Cottin et al., in 2005 and is characterised by upper lobe emphysema and lower lobe interstitial fibrosis. Patients with CPFE show severe dyspnoea and hypoxemia with exercise. Lung
Pranav Kumar, Michelle Hood
openaire   +2 more sources

Home - About - Disclaimer - Privacy